Showing results (161-170 of 1,689) with videos related to
Sort By:
Pageof 169
Transfusion Medicine (Oxford, England)|June 29, 2017
Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerationsS Hindawi, M Badawi, F Fouda, et al.Transfusion Medicine (Oxford, England)|November 18, 2003
Autologous red cells derived from cord blood: collection, preparation, storage and quality controls with optimal additive storage medium (Sag-mannitol)H S P Garritsen, T Brune, F Louwen, et al.Transfusion Medicine (Oxford, England)|November 18, 2003
Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in TaiwanK H Wu, S L Chu, J G Chang, et al.Transfusion Medicine (Oxford, England)|November 18, 2003
False-positive result of sterility testing after a supposed adverse transfusion reactionE StrobelTransfusion Medicine (Oxford, England)|December 5, 2003
New advances in acute graft-versus-host disease prophylaxisJ K Davies, M W LowdellTransfusion Medicine (Oxford, England)|December 5, 2003
The cellular immunotherapy of viral infectionP A H Moss, M Cobbold, C CraddockTransfusion Medicine (Oxford, England)|October 2, 2007
Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimenB Chaffe, J Ford, V BillsTransfusion Medicine (Oxford, England)|July 5, 2008
Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbitsY Okamura, T Fujie, M Nogawa, et al.Transfusion Medicine (Oxford, England)|July 5, 2008
Use of red blood cell indices for the identification of iron deficiency among blood donorsV Nadarajan, P Sthaneshwar, G I EowTransfusion Medicine (Oxford, England)|August 30, 2007
Production of soluble recombinant proteins with Kell, Duffy and Lutheran blood group antigen activity, and their use in screening human sera for Kell, Duffy and Lutheran antibodiesK Ridgwell, J Dixey, M L ScottPageof 169